000 05888nam a2200397 i 4500
999 _c122023
_d122023
_x1
001 122023
003 ES-MaUEC
005 20230102114159.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 200709s2020 gw a fo |||| 0|eng d
020 _a9783030459680
024 7 _a10.1007/978-3-030-45968-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRM666.C266
_b2020 EB
245 0 0 _aCannabis in Medicine :
_bAn Evidence-Based Approach
_cedited by Kenneth Finn
250 _aFirst edition
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2020
300 _a1 recurso en línea (XXXI, 554 páginas)
_b39 ilustraciones, 32 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aMedicine (SpringerNature-11650)
490 0 _aMedicine (R0) (SpringerNature-43714)
505 0 _aForward: Losing Ground: The Rise of Cannabis Culture -- Part 1: Basic Science -- Chapter 1 The Properties and Use of Cannabis sativa Herb and Extracts -- Chapter 2 Cannabinoid and Marijuana Neurobiology -- Chapter 3 The Pharmacodynamics, Pharmacokinetics, and Potential Drug Interactions of Cannabinoids -- Part 2 Clinical Evidence -- Chapter 4 Cannabis and Neuropsychiatric Effects -- Chapter 4.1 Blunted: The Effects of Cannabis on Cognition and Motivation -- Chapter 4.2 Cannabis and Psychiatric Conditions -- Chapter 4.3 Cannabis use and psychosis, mood, and anxiety disorders -- Chapter 4.4 Marijuana and Suicide: Case-control Studies, Population Data, and Potential Neurochemical Mechanisms -- Chapter 4.5 Cannabis Use Disorder, Treatment, and Recovery -- Chapter 5 Cannabis and the Impact on the Pediatric and Adolescent Population -- Chapter 5.1 Cannabis and Young Pediatric Exposures -- Chapter 5.2 Cannabis and the Teen Brain -- Chapter 6 Acute Emergency Department Presentations Related to Cannabis -- Chapter 7 Evidence of Cannabinoids in Pain -- Chapter Cannabis in Pulmonary Medicine -- Chapter 8.1 Cannabinoids and the Respiratory System -- Chapter 8.2 THC and CBD Decomposition and Terpene Hazards While Vaping or Dabbing -- Chapter 9 Clinical Cardiovascular Effects of Cannabis Use -- Chapter 10 Cannabinoids in Neurologic Conditions -- Chapter 10.1 Cannabis and Cannabinoids for the Treatment of Epilepsy -- Chapter 10.2 Multiple Sclerosis and Cannabis - Benefits, Risks, and Special Considerations -- Chapter 10.3 Evidence for Cannabis in Movement Disorders -- Chapter 10.4 Cannabinoids in Neurosurgery -- Chapter 11 Ocular Conditions and the Endocannabinoid System -- Chapter 12 Cannabis in Oncology and Symptom Management -- Chapter 13 Cannabis in Palliative Medicine -- Chapter 14 Cannabis in Older Persons -- Chapter 15 Cannabinoids in Dermatology -- Chapter 16 Fetal and Neonatal Marijuana Exposure -- Chapter 17 Cannabinoids in Gastrointestinal Disorders -- Chapter 17.1 Investigation of Cannabinoid Hyperemesis Syndrome: pathophysiology, treatment, and burden -- Chapter 17.2 Investigation of the endocannabinoid system in the pathophysiology of irritable bowel syndrome and the potential use of cannabis as a complementary and alternative medicine therapy -- Chapter 17.3 Inflammatory Bowel Disease and Cannabis -- Chapter 17.4 Cannabis in relation to Gastroesophageal Reflux Disease -- Chapter 17.5 Nonalcoholic Fatty Liver Disease and Cannabinoids -- Chapter 18 Looking at Marijuana Through the Lens of Public Health -- Chapter 19 Cannabis-Impaired Driving: Evidence and the Role of Toxicology Testing -- Chapter 20 The Legal Aspects of Marijuana as Medicine -- Epilogue/Summary.
520 _aLegalization of marijuana is becoming increasingly prominent in the United States and around the world. While there is some discussion of the relationship between marijuana and overall health, a comprehensive resource that outlines the medical literature for several organ systems, as well as non-medical societal effects, has yet to be seen. While all physicians strive to practice evidence-based medicine, many clinicians aren't aware of the facts surrounding cannabis and are guided by public opinion. This first of its kind book is a comprehensive compilation of multiple facets of cannabis recommendation, use and effects from a variety of different perspectives. Comprised of chapters dedicated to separate fields of medicine, this evidence-based guide outlines the current data, or lack thereof, as well as the need for further study. The book begins with a general overview of the neurobiology and pharmacology of THC and hemp. It then delves into various medical concerns that plague specific disciplines of medicine such as psychiatry, cardiology, gastrointestinal and neurology, among others. The end of the book focuses on non-medical concerns such as public health and safety, driving impairment and legal implications. Comprised of case studies and meta-analyses, Cannabinoids in Medicine: An Evidence-Based Approach provides clinicians with with a concise, evidence-based guide to various health concerns related to the use of marijuana. By addressing non-medical concerns, this book is also a useful resource for professionals working in the public health and legal fields.
988 _aSpringer_Medicine_2020
650 7 _2embne
_9262120
_aCannabis
_xUso terapéutico
700 1 _aFinn, Kenneth
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_1http://viaf.org/viaf/1093154381137230292793
776 0 8 _iPrinted edition:
_z9783030459673
776 0 8 _iPrinted edition:
_z9783030459697
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-45968-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b09/2020
_dz
_eb
_zSI